These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3617055)

  • 1. Antiarrhythmic effects of a novel diamine derivative, AN-132, on several animal models of cardiac arrhythmias.
    Sakai K; Yamazaki T; Takagi M
    Tohoku J Exp Med; 1987 Apr; 151(4):443-51. PubMed ID: 3617055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
    Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
    Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actions of a newly synthesized compound (711389-S) on various types of experimentally induced arrhythmias in mammalian species in situ.
    Kadowaki Y; Ohta T; Hotokebuchi N; Kimoto S; Haruna M; Nakao T; Ueda M; Nishi K
    Jpn J Pharmacol; 1988 Apr; 46(4):359-72. PubMed ID: 3404766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of bisaramil on experimental arrhythmias.
    Paróczai M; Kárpáti E; Solti F
    Pharmacol Res; 1990; 22(4):463-80. PubMed ID: 2402479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic properties of Craviten (M-71) in cats and rabbits.
    Chodera A; Banaszkiewicz W; Glinka B
    Pol J Pharmacol Pharm; 1980; 32(6):833-40. PubMed ID: 7243680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
    Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L
    Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of AH-1058, a new antiarrhythmic drug, on experimental arrhythmias and cardiac membrane currents.
    Takahara A; Uneyama H; Sasaki N; Ueda H; Dohmoto H; Shoji M; Hara Y; Nakaya H; Yoshimoto R
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):625-32. PubMed ID: 10218734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad sensitivity of rodent arrhythmia models to class I, II, III, and IV antiarrhythmic agents.
    Brooks RR; Miller KE; Carpenter JF; Jones SM
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):201-9. PubMed ID: 2726785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
    Hashimoto K; Ishii M; Komori S; Mitsuhashi H
    Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic effects of two new propafenone related drugs. A study on four animal models of arrhythmia.
    Wascher TC; Dittrich P; Kukovetz WR
    Arzneimittelforschung; 1991 Feb; 41(2):119-24. PubMed ID: 2043172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiarrhythmic effects of crebanine].
    Yu ZP; Mu YS; Zhao ZX; Wang FC
    Zhongguo Zhong Yao Za Zhi; 1992 Nov; 17(11):685-7, 704. PubMed ID: 1301759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs for treatment of ventricular arrhythmias.
    Heger JJ; Prystowsky EN; Zipes DP
    Heart Lung; 1981; 10(3):475-83. PubMed ID: 6785255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
    Singh BN; Cho YW; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):185-99. PubMed ID: 6788721
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine.
    Komori S; Sawanobori T; Tamura K; Kane KA; Parratt JR
    Jpn J Pharmacol; 1994 Jul; 65(3):193-200. PubMed ID: 7799519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs.
    Mest HJ; Thomsen P; Raap A
    Ann N Y Acad Sci; 1995 Jul; 763():620-33. PubMed ID: 7677382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative chronotropic but no antiarrhythmic effect of (+)- and (-)-naloxone in rats and guinea pigs.
    Kaschube M; Brasch H
    Cardiovasc Res; 1991 Mar; 25(3):230-4. PubMed ID: 2029712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
    Nakayama K; Oshima T; Koike H
    Jpn J Pharmacol; 1979 Dec; 29(6):935-45. PubMed ID: 44326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental anti-arrhythmic properties of melperone, a neuroleptic butyrophenone.
    Petersen EN
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):388-94. PubMed ID: 581034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.